Delta Air Lines Inc
NYSE: DAL
$45.30
-$1.38 (-3.0%)
Closing Price on March 12, 2025
DAL Articles
These are not the only key analyst calls coming out of Wall Street analysts today, but these are the key calls that a673b.bigscoots-temp.com is focusing on in pre-market hours: AU Optronics (AUO) raised to...
Published:
It is unusual to see this many 52-week lows in big cap stocks, but many of these are credit or oil-price related. US Air (LLC) down to $13.50. Northwest Air (NWA) down to $13.80. American (AMR) down...
Published:
Pardus Capital Management, which has taken a position in Delta (DAL), is going to push a merger with United (UAUA) by taking the proposal to other shareholders. Odd as it may seem, the meeting will...
Published:
According to Reuters, Barclays (BCS) took a $2.7 billion write-down due to exposure to subprime markets. Reuters writes that IBM (IBM) will push into the business of running huge data centers for...
Published:
Delta Air Lines (NYSE:DAL) has canned the notions and the reports on Wall Street and Main Street that it is in merger dicusssions with United Airlines’ parent UAL Corp. ...
Published:
Last Updated:
Rising fuel costs did not kill off a good quarter for Delta (DAL). The airline’s quarterly operating revenue of $5.2 billion for the September quarter was the highest in Delta’s history. Net...
Published:
(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock...
Published:
AMR raised to Neutral at UBS.BEAS raised to Outperform at Credit Suisse.BHP cut to Hold at Deutsche Bank.BTU cut to Neutral at HSBC.COGN raised to Strong Buy at JMP Securities.CPA raised to...
Published:
With oil hanging around $70, and gas likely to move above $3 for all of the summer, it bears looking at who gets hurt: Airlines: It looked like they might get something of a recovery. Now, firms...
Published:
JetBlue (JBLU) in a filing with the SEC, said that its operating margins in Q2 would be 9% to 11%, which was higher than previously forecast. But, the stock managed to go nowhere, up about 1% to...
Published:
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.